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Abstract
Background: Streptococcus agalactiae (group B streptococcus; GBS) is a significant cause of perinatal and neonatal
infections worldwide. To detect GBS colonization in pregnant women, the CDC recommends isolation of the
bacterium from vaginal and anorectal swab samples by growth in a selective enrichment medium, such as Lim
broth (Todd-Hewitt broth supplemented with selective antibiotics), followed by subculture on sheep blood agar.
However, this procedure may require 48 h to complete. We compared different sampling and culture techniques
for the detection of GBS.
Methods: A total of 300 swabs was taken from 100 pregnant women at 35-37 weeks of gestation. For each
subject, one rectovaginal, one vaginal and one rectal ESwab were collected. Plating onto Columbia CNA agar
(CNA), group B streptococcus differential agar (GBSDA) (Granada Medium) and chromID Strepto B agar (CA), with
and without Lim broth enrichment, were compared. The isolates were confirmed as S. agalactiae using the CAMP
test on blood agar and by molecular identification with tDNA-PCR or by 16S rRNA gene sequence determination.
Results: The overall GBS colonization rate was 22%. GBS positivity for rectovaginal sampling (100%) was
significantly higher than detection on the basis of vaginal sampling (50%), but not significantly higher than for
rectal sampling (82%). Direct plating of the rectovaginal swab on CNA, GBSDA and CA resulted in detection of 59,
91 and 95% of the carriers, respectively, whereas subculturing of Lim broth yielded 77, 95 and 100% positivity,
respectively. Lim broth enrichment enabled the detection of only one additional GBS positive subject. There was
no significant difference between GBSDA and CA, whereas both were more sensitive than CNA. Direct culture onto
GBSDA or CA (91 and 95%) detected more carriers than Lim broth enrichment and subculture onto CNA (77%).
One false negative isolate was observed on GBSDA, and three false positives on CA.
Conclusions: In conclusion, rectovaginal sampling increased the number GBS positive women detected, compared to
vaginal and/or rectal sampling. Direct plating on CA and/or GBSDA provided rapid detection of GBS that was at least as
sensitive and specific as the CDC recommended method of Lim broth subcultured onto non chromogenic agar.
Background
Streptococcus agalactiae (group B streptococcus, GBS) is
a significant cause of perinatal and neonatal infections
worldwide. Rectovaginal colonization occurs in 10 to
30% of pregnant women [1-3] and is responsible for 1.8
neonatal infections per 1,000 live births per year [4]. In
Belgium, 13 to 25% of pregnant women are colonized
with GBS. GBS is responsible for 38% of early neonatal
infections [5].
GBS can be acquired during labor or in utero
by transmission from maternal vaginal or anorectal-
colonized mucosa. Prematurity is also a risk factor for
GBS neonatal sepsis, and mortality due to GBS is higher
in preterm than in term newborns [6]. Because results
at 35-37 weeks correlate more closely with GBS coloni-
zation at term delivery, the Centers for Disease Control
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and Prevention (CDC) has recommended that all preg-
nant women be screened for carriage of GBS at between
35 and 37 weeks of gestation [7], so that GBS positive
women can receive antibacterial treatment (chemopro-
phylaxis) prior to delivery, to reduce mother-to-child
transmission.
To maximize GBS carriage detection rates, both the
anatomic site of sampling and the culture methods used
are important. Rectovaginal swabs have been reported to
provide high bacterial yields, as the gastrointestinal tract
is a natural reservoir for GBS and a potential source of
vaginal colonization [7-11]. In the present study, we
compared three sampling techniques, i.e. rectovaginal
swabbing, vaginal swabbing only and rectal swabbing
only, using the ESwab, a nylon flocked swab in liquid
Amies transport medium (Copan, Brescia, Italy), which,
according to the manufacturer, is a liquid-based multi-
purpose collection and transport system that maintains
viability of aerobic, anaerobic and fastidious bacteria for
up to 48 hours at room and refrigerator temperature,
and suitable for automation, gram stains, and traditional
culture, and which compares well to other swabs with
regard to species recovery [12,13].
With regard to bacterial culture, the CDC recom-
mends isolation of the bacterium from vaginal and rectal
swabs by growth in a selective enrichment medium,
such as Lim broth, i.e. Todd-Hewitt broth with colistin
and nalidixic acid, followed by subculture on sheep
blood agar. In the same guidelines, the CDC identified
various research priorities, including ‘the development
of media with a reliable color indicator to signal the
presence of GBS to improve accuracy of prenatal culture
results and facilitate prenatal culture processing at clini-
cal laboratories with limited technical capacity’ [14].
Therefore, in the present study, we also determined
the sensitivity and specificity of two types of color indi-
cator based media that are commercially available for
detecting GBS carriage in pregnant women, with that of
the CDC recommended method, i.e. Lim broth enrich-
ment with subculture onto sheep blood agar.
The first type, designated Granada Medium (GM)
[15], is an adaptation of Islam’s medium [16], and
exploits the ability of GBS to synthesize - under anaero-
bic conditions and on media containing starch and
serum - an orange pigment, recently identified as grana-
daene [17].
This method is very specific and simple, thereby
allowing identification of GBS in a single step within 24
h. Later, a modification of GM was described as new
GM [15]. In this study, we used group B streptococcus
differential agar (GBSDA, Becton Dickinson), which is
itself a modification of new GM and of which the manu-
facturer claims that it has improved selectivity and stabi-
lity compared to new GM, without further specification.
The second type of medium used in this study, recently
developed by bioMérieux as chromID™ Strepto B agar
(CA), is a selective chromogenic medium, of which the
constituents are not specified by the company, and which
enables the recognition of S. agalactiae as pink to red,
round and pearly colonies, without the need of anaerobic
incubation. Most other bacterial species are either inhib-
ited or the colonies produced have a different colour (e.g.
violet, blue, colourless) [18-20].
In summary, in addition to comparing three sampling
methods, we compared six different culture methods,
i.e. direct culture onto Columbia Colistine Nalidixic
Acid Agar (CNA), GBSDA and CA, and Lim broth
enrichment with subculture on these three agars.
Methods
Study design
The study was approved by the research ethics commit-
tee (IRB protocol nr 2007/096) of the Ghent University
Hospital, Flanders, Belgium, and all the women gave
written informed consent. Between June 2009 and Janu-
ary 2010, 100 vaginal samples, 100 rectal and 100 recto-
vaginal ESwab samples were collected from 100 pregnant
women at 35 - 37 weeks of gestation, i.e. three different
samples per subject.
Collection and culture of specimens
Rectovaginal, vaginal and rectal samples were collected
using nylon flocked swabs that were submerged into 1
ml of ESwab transport medium (ESwab, Copan Diagnos-
tics, Brescia, Italy).
Rectovaginal sampling was carried out by rotating an
ESwab against the vaginal wall at the midportion of the
vault. Subsequently, the swab was carefully withdrawn
to prevent contamination with microflora from the
vulva and introitus and the swab was inserted 1.5 to 2
cm beyond the anal sphincter and gently rotated to
touch the anal crypts. Next, vaginal sampling was car-
ried out by inserting the ESwab following the same pro-
cedure described above for swabbing the vaginal wall.
Finally, an ESwab was used for rectal sampling as
described above for the anal procedure of the rectovagi-
nal sampling.
All samples were collected by midwives and trans-
ported to the Laboratory of Bacteriology Research
within 4 hours. Direct plating was carried out only for
the rectovaginal ESwab, by inoculating 50 μl from the
ESwab transport medium onto Columbia agar with 5%
sheep blood and with 10 mg/ml colistin and 15 mg/ml
nalidixic acid (CNA, Becton Dickinson, Erembodegem,
Belgium), 50 μl onto group B streptococcus differential
agar (GBSDA, Becton Dickinson) and 50 μl onto chro-
mID™ Strepto B agar (CA, BioMérieux, Marcy l’Etoile,
France). The CNA plates were incubated at 37°C in 5%
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CO2 for 24-48 h, the GBSDA plates were incubated at
37°C in an anaerobic chamber (BugBox, LedTechno,
Heusden-Zolder, Belgium) for 24-48 h, and the CA
plates were incubated at 37°C for 18-24 hours in aerobic
conditions in the dark. Volumes of 200 μl from the
ESwab transport medium of the rectovaginal, vaginal
and rectal ESwabs were inoculated into separate tubes
with 5 ml of Todd-Hewitt broth with 1% yeast extract,
15 μg/ml nalidixic acid and 10 μg colistin/ml (Lim
broth, Becton Dickinson), which were incubated aerobi-
cally at 37°C and subcultured onto CNA, GBSDA and
CA after overnight incubation. GBSDA was examined
for yellow-orange pigment colonies indicative of the pre-
sence of GBS, whereas CA was examined for pale pink
to red, round and pearly colonies. b-haemolytic and
non-haemolytic colonies were picked from CNA for
further identification (Figure 1). The isolates were con-
firmed as S. agalactiae using the CAMP test on sheep
blood agar. GBS colonies with discrepant results (either
false positive on CA or false negative on GBSDA) were
identified using tDNA-PCR, as described previously
[21], and by 16S rRNA gene sequence determination.
Figure 1 Appearance after 24 h incubation of (A): Streptococcus agalactiae (Group B Streptococcus (GBS) and (B) Enterococcus faecalis
on GBSDA, (C) GBS and (D) Enterococcus faecalis on Strepto B ID® chromogenic agar and (E) GBS and (F) Enterococcus faecalis on CNA.
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Statistical methods
The McNemar test for correlated percentages was used
to compare the sensitivity of the culture methods. The
total number of positive subjects (22) was taken as
100%, to calculate sensitivities, specificities, positive and
negative predictive values of the different sampling and
culture methods.
Results
A total of 300 swabs was taken from 100 pregnant
women at 35-37 weeks of gestation, and 49 of these
swabs were positive for a total of 22 subjects. Data for
each subject, sampling site and method and culture
method are listed in additional file 1, Table 1. GBS
could be cultured from all 22 rectovaginal swabs,
although one was only positive after Lim broth enrich-
ment. Of the 22 GBS positive subjects, GBS could be
cultured for nine from both the rectal and vaginal
swabs, for two only from the vaginal swab, and for nine
exclusively from the rectal swabs. For another two
women, only the rectovaginal swab was positive.
The GBS detection rate on the basis of rectovaginal
samples (22 GBS positive women) were significantly
higher than the detection rate on the basis of vaginal
samples (11 positive) (P = 0.01), but not significantly
higher than that on the basis of rectal samples (18 posi-
tive) (P = 0.12).
Direct plating of the rectovaginal swabs on CNA,
GBSDA and CA resulted in detection of 59, 91 and 95%
respectively of the total number of carriers detected on
all samples and media, whereas Lim broth with subcul-
ture onto on CNA, GBSDA and CA resulted in positiv-
ities of 77, 95 and 100% respectively (Table 1). For all
sampling methods, and for the rectovaginal swab with
and without enrichment, GBSDA and CA detected more
positive women than CNA. In addition, detection of
GBS from rectovaginal specimens by direct plating onto
GBSDA or CA was equally sensitive as detection by Lim
broth enrichment with subculture on these agars (P = 1)
and only one pregnant woman (RVS001) was identified
as GBS-positive only after Lim broth enrichment. It
should be noted that the inoculum of GBS in this sub-
ject was low, as only a few colonies were observed on
the agars, even after the enrichment incubation. One
false-negative result on GBSDA, i.e. a colony without
orange pigmentation, corresponded to a non-haemolytic
and non-pigmented GBS strain that was correctly identi-
fied on CA. Three false positives for three different
women were observed on CA, because the red colonies
isolated from CA were all three identified as Streptococ-
cus anginosus, by means of 16S rRNA gene sequence
determination and/or tDNA-PCR [21].
Discussion
This study intended to compare the sensitivity of differ-
ent sampling and culture procedures to establish the
presence of GBS in pregnant women. We compared i)
rectovaginal, vaginal and rectal sampling, and ii) culture
on Columbia CNA agar (CNA), on group B streptococ-
cus differential agar (GBSDA) and on Chromogenic
Strepto B ID Agar (CA), iii) directly and after Lim broth
enrichment. Other groups studying chromogenic agar
did so only for vaginal samples [18-20,22], whereas we
also included the CDC recommended rectovaginal sam-
pling method, or they did not compare to Granada agar
and used miscellaneous samples [23].
A limitation of this study may be the limited sample
size of one hundred subjects, although it should be
noted that each subject was studied intensively, i.e. three
different sampling sites and six different culture meth-
ods were compared for each subject, in a strictly
designed study setup that enabled to compare the cul-
ture results for each subject in a direct and unambigu-
ous manner.
Comparison of rectovaginal, vaginal and rectal sampling
We found that rectovaginal swabbing was the best sam-
pling method to detect GBS colonization of pregnant
women, because all 22 GBS positive women in this
study were detected by means of rectovaginal sampling
and because two subjects were GBS positive only on the
basis of the rectovaginal swab. Our results correspond
with previous reports that GBS colonization of rectal
samples is 18% to 24% higher than that of vaginal sam-
ples [24,25] and with those of other studies that find
rectovaginal sampling more appropriate than vaginal
sampling only [7,26,27]. For example, in an analysis of
651 specimens, the combination of separate rectal and
Table 1 Number of GBS culture positive samples detected by different culture media in rectovaginal, vaginal and
rectal specimens obtained from 49 GBS positive samples from 22 GBS positive women
Specimen CNA GBSDA CA Lim-CNA Lim- GBSDA Lim- CA Estimated number of women colonized
Rectovaginal ESwab 13 20 21 17 21 22 22
Vaginal ESwab NT NT NT 9 11 11 11
Rectal Eswab NT NT NT 13 17 18 18
CA: Chrom ID Strepto B agar (BioMérieux), CNA: colistin nalidixic acid Columbia agar, GBSDA: GBS Differential Agar (Becton Dickinson), Lim: Lim broth.
NT: Not tested.
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vaginal sampling enabled detection of 97.8% of GBS car-
riers, compared to 31.8% of positives as established by
vaginal sampling only [28]. Although our results are in
correspondence with the CDC recommendations to
carry out rectovaginal sampling, it should be noticed
that Nomura et al. [29] found no significant difference
in detection rates between vaginal and rectal samples
and Gupta & Briski [30] reported a similar detection
rate of 23.8% of GBS when using rectovaginal and vagi-
nal sampling. Votava et al. [11] even found that the
GBS detection rate using rectovaginal samples was only
16.9%, whereas the use of separate vaginal and rectal
swabs yielded 22.7 and 24.1% GBS positive women,
respectively. Also, several obstetric departments still use
vaginal sampling only to assess GBS positivity.
It is worthwhile mentioning that we also compared
vaginal sampling using the recently marketed ESwab
with vaginal sampling using the classical cotton swab in
Amies gel transport medium (Nuova Aptaca, Canelli,
Italy) for the detection of GBS (data not presented to
increase readability of the manuscript). Both swabs were
introduced simultaneously into the vagina and culture
was carried out in an identical manner for both swabs.
The classical swab could detect two more GBS positive
subjects than the ESwab, raising the number of women
positive for GBS in the vagina from 11 to 13.
Different types of selective media formulations
Different selective media for the improved isolation of
GBS have been described. Islam et al. [16] showed that
adding horse serum and starch to agar based media
increased the orange/red pigment formation, that was
already present to some degree on Columbia agar and
that was typical for GBS, being absent for all other sero-
types. De la Rosa et al. [31] improved this medium add-
ing horse serum at 90 to 95°C instead of at 55°C,
making the agar opaque and increasing the natural pig-
mentation of the colonies, specific for S. agalactiae.
They showed that pigmentation depends strongly on the
use of the correct starch and of proteose peptone n°3
and that it was further increased by the addition of the
folate inhibitor trimethoprim (15 μg/ml), in combination
with anaerobic incubation. This medium was designated
Granada Medium (GM). The same authors later
improved GM, which they designated as New Granada
medium (NGM) [15], by replacing trimethoprim with 6
μg/ml methotrexoate, which is also a folate synthesis
inhibitor, but further increases orange to salmon pig-
mentation of the GBS colonies, and by adding 0.2 μg/ml
crystal violet, 5 μg/ml colistin sulphate and 10 μg/ml
metronidazole as selective agents. It should be noted
that horse serum was added again at 55°C. The com-
mercially available group B streptococcus differential
agar (GBSDA), that was used in this study, is a modifi-
cation of NGM with improved stability and selectivity,
not further specified by the company. Its usefulness has
been evaluated in several studies [9,32-34]. Bou et al.
[32] found that the intensity of colony pigmentation on
GBSDA is stronger than on GM and that the commen-
sal microflora is more suppressed.
Because different modifications have been used, some-
times also designated as GM, or because the media were
home made [35] or prepared by other companies than
the one that supplied the GBSDA in this study [30,36],
or because other selective media were used [8,37,38], it
is difficult to compare the outcome of several of the
previous studies with this study. Therefore, we largely
limit our comparison to studies that explicitly used CA
from BioMérieux and/or GBSDA from Becton
Dickinson.
Direct plating vs broth enrichment culture
Possibly, the use of different (commercial) preparations,
modifications and designations, as mentioned above,
may explain why some studies found comparable sensi-
tivity of direct plating on ‘Granada Medium’ compared
with Lim broth enrichment [11,15,39,40], whereas other
studies found direct plating on chromogenic and/or
selective media significantly less sensitive [30,36].
Blanckaert et al. [41] suggested to use a combination of
Granada and Columbia blood agar and an adequate
sample (rectovaginal swab in transport medium) for
optimal GBS screening.
In our study, the sensitivity of direct plating on CA
and GBSDA was comparable to that of plating on
CAand GBSDA after Lim broth enrichment, whereby
the latter enabled the detection of only one additional
sample, leading to 22 GBS (22%) positive women. Our
data suggest that CA and GBSDA are not only faster
and easier to use than the CDC recommended method,
but that they are also at least as sensitive for the detec-
tion of GBS, in agreement with several other recent stu-
dies. Also Tazi et al. [18] found that, compared to CA
and GBSDA, Lim broth enrichment enabled the detec-
tion of only two additional samples leading to 34 (17%)
GBS positive cultures. Also in the study of Bou et al.
[28], only one swab was only positive following subcul-
ture in Lim broth and was missed on direct GBSDA
[32]. Adler et al. [34] reported that GBSDA is not only
faster and easier to use than Lim broth combined with
antigen detection or with subculture on blood agar, but
is also at least as sensitive for the detection of GBS from
vaginal swabs. In addition, Dunne et al. [8] reported that
direct plating on neomycin nalidixic acid agar reduced
the potential of enterococci competitively overgrowing
and masking the presence of GBS in the Lim broth, and
this ultimately increased the sensitivity of the direct
assay by 14%.
In conclusion, although we missed one out of 22 car-
riers by direct plating on CA and GBSDA, in our hands
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direct plating on CA and GBSDA provided high sensi-
tivity for GBS detection among pregnant women.
CA and GBSDA vs colistin nalidixic acid selective agar (CNA)
We found that CA and GBSDA had comparable sensitivity
and provided superior recovery of GBS when compared
with CNA. This difference was even more apparent for
direct plating. Also, the single subject (RVS072) positive
only for the rectovaginal swab was so only on CA and
GBSDA, but not on CNA. This is in agreement with
another study [30] that showed that selective media pro-
ducing pigmented colonies are more sensitive in GBS
detection than enriched media like blood agar or selective
media like CNA.
Direct plating on CA and GBSDA offers the advantage
of reducing workload and providing an identification of
GBS 24 h sooner than the Lim broth enrichment
method. In this study, all GBS isolated from CA and
GBSDA were identified within 1-2 days of specimen
receipt, whereas all Lim broth enrichment cultures
required a minimum of 2-3 days for the identification of
specimens positive for GBS. In addition, CA offers an
additional advantage with respect to GBSDA, because
culture on CA can be carried out aerobically, not requir-
ing special equipment and extra costs and workload
associated with anaerobic culture needed for GBSDA.
Sensitivity, specificity, positive and negative predictive
value of GBS detection with CA versus GBSDA
The sensitivity and positive predictive value of direct
plating of CA for GBS detection were 100 and 87,
respectively (Table 2), whereas these values for direct
plating on GBSDA were 95 and 100, respectively. In this
study, one false negative isolate, lacking the orange pig-
ment, was found on GBSDA, for subject RVS041. This
isolate was not missed on CA and was confirmed as
GBS by means of the CAMP test. Also Tazi et al. [18]
found two false negative isolates on Granada medium.
Non-haemolytic and non-pigmented GBS have been
reported to occur in 1 to 4% among pregnant women
[11,30,36,39,40]. Pigment is produced by 93 to 98.5% of
GBS clinical isolates. There is a high correlation
between the capacity to produce pigment and the
capacity to release hemolysin [42,43], since the genes
that determine these properties are in contiguous loci
on the chromosome [40].
In our study, we found three false positive results with
CA after 24 hrs of incubation, whereby all three isolates
were identified as Streptococcus anginosus. Tazi et al.
[18] found two false positive results on Chromagar and
showed that these corresponded either to Streptococcus
pyogenes or S. porcinus. These observations indicate that
colonies that grow on CA and are suspected to be GBS
must be confirmed by additional tests such as CAMP,
latex agglutination or molecular techniques, or by posi-
tivity on GBSDA. It may be suggested that the combina-
tion of direct plating onto CA with aerobic incubation
(95% sensitivity), with confirmation of CA positive iso-
lates by means of the CAMP test (100% specificity), may
be a highly sensitive, specific and cost effective manner
to detect GBS from pregnant women.
Conclusions
In conclusion, to detect GBS carriage among pregnant
women, our results indicate i) that rectovaginal sampling
is the preferred sampling method, ii) that the ESwab is
not superior to the classical cotton swab for sampling,
iii) that the inoculation of rectovaginal specimens
directly onto CA (21 positives/22) and/or GBSDA (20
positives) has comparable sensitivity as enrichment by
Lim broth (22 and 21 positives after subculture onto CA
and GBSDA, respectively), and iv) that direct inoculation
onto CA or GBSDA is at least as sensitive as the recom-
mended CDC method, i.e. overnight Lim broth enrich-
ment followed by plating onto sheep blood agar (which
in this study was replaced by CNA: 17 positives).
Direct inoculation offers several advantages such as
decreased workload, because no subculture is needed,
and decreased time to detection, i.e. at least 24 hours
faster than the standard method. Reagent costs of using
CA or GBSDA may be comparable to Lim broth enrich-
ment and subculture on blood agar, also because addi-
tional testing is rarely needed for the former approach.
Plating on CA in addition does not require anaerobic
incubation as is the case for GBSDA. The specificity
Table 2 Sensitivities, specificities, positive and negative predictive values for the six different culture methods, based
on all 300 samples, and calculated for a number of 22 positive subjects on a total number of 100 subjects included
Culture Medium % Sensitivity % Specificity % Positive predictive value % Negative Predictive value
CNAa 56 84 52 86
GBSDA 95 100 100 99
CA 100 96 87 100
Lim broth + CNA 78 84 60 93
Lim broth + GBSDA 96 100 100 99
Lim broth + CA 100 96 88 100
a: False positive on CNA: beta-hemolytic colonies which were CAMP negative.
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problems associated with the use of CA can be resolved
by confirmation of CA positive isolates with the CAMP
test.
Additional material
Additional file 1: Table 1: Detection of GBS by means of culture on
different media for vaginal, rectal and rectovaginal samples from
22 GBS positive pregnant women. Three samples were collected from
pregnant women (vaginal, rectal and rectovaginal). The rectovaginal
samples were cultured directly and after Lim broth enrichment on the
following media (CNA, GBSDA and CA) whereas vaginal and rectal
samples were cultured only after Lim broth enrichment on the same
three media.
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